Session Details

Speakers, titles, times, and locations of ASGCT presentations

Detailed Program

1212: Comprehensive Genomic Profiling of Human CD19 CAR T-cells Engineered with a Mammalian Transposon

Disclosures:   A.O. Vershinina: 1; Commercial Interest i.e. Company X; SalioGen Therapeutics. 1; What was received? i.e. Honorarium; Salary, Equity. 1; For what role? i.e. Speaker; Employee.

Related Abstract

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.